Pharma Sessions

Small Team, Big Impact: Life as The First MSL in a Biotech Startup with Orlando Granado-Balaez


Listen Later

Life is different at a biotech. But is that a good thing?

Like so much in life, the answer is, "it depends."

On this episode I speak with Orlando Granado-Balaez about his journey from being a nurse to transitioning into medical affairs and ultimately thriving in smaller pharmaceutical companies. 

He shares his experiences in different roles within medical affairs, including being the first MSL in a company and the challenges and rewards that come with building out a team. 

Orlando also provides advice for individuals considering a transition from larger companies to start-up environments in medical affairs, emphasizing understanding the role, asking right questions, and maintaining a learning mindset.

00:00 Introduction to the Podcast

00:25 The Journey from Big Pharma to Biotech

01:21 Personal Career Path and Transition into Medical Affairs

02:49 The Appeal of Startups and the Concept of Pivoting

03:30 Experience in Small Pharma and the Transition from Big Companies

05:09 Building a Medical Affairs Team from Scratch

06:02 The Challenges and Rewards of Leadership in a Startup

07:57 The Hiring Process and Building a Team

09:59 The Importance of Fit and Transparency in Hiring

11:07 The Role of Consultation and Networking in Career Transition

26:04 The Future of Medical Affairs and Final Thoughts

Pharma Sessions is hosted by Jonathan Kaskey

Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

Or join the Pharma Sessions Substack:
www.pharmasessions.substack.com

...more
View all episodesView all episodes
Download on the App Store

Pharma SessionsBy Jonathan Kaskey

  • 5
  • 5
  • 5
  • 5
  • 5

5

3 ratings


More shows like Pharma Sessions

View all
HBR IdeaCast by Harvard Business Review

HBR IdeaCast

1,856 Listeners

TED Business by TED

TED Business

1,110 Listeners

The Journal. by The Wall Street Journal & Spotify Studios

The Journal.

5,957 Listeners

HBR On Strategy by Harvard Business Review

HBR On Strategy

72 Listeners